Unlocking the Future of Pharma Strategy: How to Track Global Drug Patent Expiry Without a Massive Team
In the fiercely competitive world of pharmaceuticals, timing is everything. The expiration of a drug patent can open the floodgates for generic compe…

Is Your Oncology Sales Pipeline at Risk? How to Capitalize on the Patent Cliff Before It’s Too Late
In the rapidly evolving landscape of oncology therapeutics, the looming expiration of patents—commonly known as the "patent cliff"—poses both …

In the high-stakes world of biopharmaceutical innovation, timing isn’t just everything—it’s the difference between leading the market and playing catch-up. As the patent cliff approaches for blockbuster biologics, a new frontier emerges: biosimilars. B…

In the high-stakes world of pharmaceuticals, the phrase “proving sameness” has never carried more weight—or more controversy. As the global healthcare industry grapples with soaring drug prices and the urgent need for affordable medicines, a seismic sh…

In the relentless race to bring life-saving drugs to market, the path from discovery to approval is often fraught with delays, hefty costs, and unpredictable hurdles. But what if there was a smarter, more efficient route—one that could streamline devel…

In the high-stakes world of pharmaceutical innovation, the recent passage of the Inflation Reduction Act (IRA) has sent shockwaves through industry corridors and policy halls alike. But beyond the headlines and political debates lies a complex reshapin…

The Patent Wall Is Crumbling: How Secondary Abandonment Is Reshaping the Future of Drug Innovation
In the high-stakes world of pharmaceuticals, patent protection has long been the fortress guarding billions in revenue and the promise of innovation. But…

In the fiercely competitive world of pharmaceuticals, innovation alone isn’t enough. Success hinges on strategic foresight—knowing when and how to secure the right patent licenses to unlock market potential and maximize ROI. Yet, many companies stumble…

In the relentless race to develop groundbreaking new medicines, the pharmaceutical industry often overlooks a game-changing strategy: drug repurposing. While the traditional approach focuses on discovering novel compounds, a growing body of evidence su…

Unlocking the Hidden Barriers to Generic Drug Entry: Beyond the API Patent
In the high-stakes world of pharmaceuticals, the race to bring affordable generics to market is often viewed through the lens of primary patents—those obvious, blockbuster prote…